Coronavirus company news summary – QuantLase Imaging Lab develops rapid Covid-19 laser testing equipment – Medela ramps up production to meet Covid-19 demand for suction systems

20 May 2020 (Last Updated May 20th, 2020 09:23)

UAE-based QuantLase Imaging Lab has developed novel equipment that can carry out faster mass screenings for Covid-19 and provides test results in seconds. Emirates News Agency reported that this technology aid in carrying out testing on a larger scale and will ‘reinforce the UAE’s position as a hub of research and innovation’. The lab aims to roll out the technology to the market in the next few months and has so far produced results with increased accuracy in an ideal control setup.

G Medical Innovations Holdings has received Emergency Use Authorisation (EUA) from the US Food and Drug Administration (FDA) for its Vital Signs Monitoring System (VSMS) ECG Patch (Patch). This technology is used to monitor the QT interval of ECG of the patients who are undergoing Covid-19 treatment in a hospital, with drugs that can prolong QT intervals.

Roche’s Elecsys Anti-SARS-CoV-2 antibody test is now available at over 20 commercial and hospital lab sites in the US. The company plans to increase the availability to over 200 sites, with the capability to carry out millions of tests each week. Earlier this month, FDA provided an EUA for the Elecsys Anti-SARS-CoV-2 antibody test. This test can identify mature antibodies that are developed later in the immune response, thereby reducing the probability of a false positive result.

Medela has launched a new US production line of its Vario 18 AC Portable Suction Pumps and estimates that around 10,000 units will be produced and provided by August. Additionally, the company has also tripled its Swiss production of Vario 18, Dominant Flex and Basic and other surgical and airway suction pumps. These devices offer necessary suction and fluid removal during respiratory treatment using ventilators.